Please login to the form below

Not currently logged in
Email:
Password:

aromatic amino acid decarboxylase deficiency

This page shows the latest aromatic amino acid decarboxylase deficiency news and features for those working in and with pharma, biotech and healthcare.

Positive CHMP opinion issued for PTC Therapeutics’ Upstaza

Positive CHMP opinion issued for PTC Therapeutics’ Upstaza

The therapy will be the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency for patients who are 18 months and older, and will be the first ... There are currently no approved disease-modifying treatments

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...